Unique ID issued by UMIN | UMIN000027778 |
---|---|
Receipt number | R000031839 |
Scientific Title | Drug Use-results survey for Mantle cell lymphoma of Velcade Injection 3mg |
Date of disclosure of the study information | 2017/06/19 |
Last modified on | 2024/09/03 11:46:23 |
Drug Use-results survey for Mantle cell lymphoma of Velcade Injection 3mg
Drug Use-results survey for Mantle cell lymphoma of Velcade Injection 3mg
Drug Use-results survey for Mantle cell lymphoma of Velcade Injection 3mg
Drug Use-results survey for Mantle cell lymphoma of Velcade Injection 3mg
Japan |
Mantle cell lymphoma
Hematology and clinical oncology |
Malignancy
NO
To primarily investigate the safety of VELCADE Injection 3 mg (hereinafter referred to as VELCADE) under actual conditions of use in patients with mantle cell lymphoma (MCL), and also to examine efficacy.
Safety,Efficacy
Safety(Adverse Drug Reaction)
Effectiveness(Best assessment result)
Observational
Not applicable |
Not applicable |
Male and Female
Patients with untreated MCL who receive VELCADE (in combination with R-CAP) for the first time.
NA
50
1st name | Takeshi |
Middle name | |
Last name | Koyama |
Janssen Pharmaceutical K.K
Medical Affiars Delivery Unit
101-0065
5-2, Nishi-Kanda 3-chome, Chiyoda-ku, Tokyo
-
tkoyama4@ITS.JNJ.com
1st name | Hirokazu |
Middle name | |
Last name | Shirai |
Janssen Pharmaceutical K.K
Medical Affiars Delivery Unit
101-0065
5-2, Nishi-Kanda 3-chome, Chiyoda-ku, Tokyo
-
hshirai3@ITS.JNJ.com
Janssen Pharmaceutical K.K
Janssen Pharmaceutical K.K
Profit organization
Janssen Pharmaceutical K.K
5-2, Nishi-Kanda 3-chome, Chiyoda-ku, Tokyo
NA
hshirai3@ITS.JNJ.com
NO
2017 | Year | 06 | Month | 19 | Day |
Unpublished
No longer recruiting
2015 | Year | 06 | Month | 19 | Day |
2015 | Year | 06 | Month | 19 | Day |
2015 | Year | 09 | Month | 08 | Day |
2022 | Year | 12 | Month | 17 | Day |
Drug use result survey
2017 | Year | 06 | Month | 16 | Day |
2024 | Year | 09 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031839